Northwire Canada EditionTuesday, July 14, 2026
Sign inSubscribe
Northwire
⌕
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%

Healthcare

Page 48
  1. Mar 16, 2026 · 07:30 · CTX

    Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium

    Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium

    01
  2. Mar 16, 2026 · 07:00 · MDX

    MedX Announces Application for Extension of Non-Brokered Private Placement

    MedX Announces Application for Extension of Non-Brokered Private Placement

    02
  3. Mar 13, 2026 · 20:41 · CHS

    Comprehensive Healthcare extends private placement

    Comprehensive Healthcare extends private placement

    03
  4. Mar 13, 2026 · 20:15 · CHS

    Comprehensive Healthcare Systems Announces Extension of Second Tranche of Private Placement

    Comprehensive Healthcare Systems Announces Extension of Second Tranche of Private Placement

    04
  5. Mar 13, 2026 · 18:43 · NURS

    Hydreight closes acquisition of 800,000 Insu units

    Hydreight closes acquisition of 800,000 Insu units

    05
  6. Mar 13, 2026 · 17:06 · SHRX

    Sharp Therapeutics Announces Closing of Second Tranche of Unsecured Convertible Note Offering

    Sharp Therapeutics Announces Closing of Second Tranche of Unsecured Convertible Note Offering

    06
  7. Mar 13, 2026 · 16:15 · NURS

    Hydreight Technologies Closes Strategic Investment in Insu Therapeutics

    Hydreight Technologies Closes Strategic Investment in Insu Therapeutics

    07
  8. Mar 13, 2026 · 10:30 · PRN

    CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure(TM) to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence

    CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure(TM) to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence

    08
  9. Mar 13, 2026 · 04:44 · ONCO

    Onco-Innovations closes $1.21M private placement

    Onco-Innovations closes $1.21M private placement

    09
  10. Mar 12, 2026 · 21:03 · EPRX

    Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results

    Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results

    10
  11. Mar 12, 2026 · 17:30 · RX

    BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026

    BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026

    11
  12. Mar 12, 2026 · 17:00 · ONCO

    Onco-Innovations Announces Closing of Private Placement

    Onco-Innovations Announces Closing of Private Placement

    12
  13. Mar 12, 2026 · 17:00 · CPH

    Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings

    Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings

    13
  14. Mar 12, 2026 · 16:15 · NGEN

    NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange

    NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange

    14
← Newer Older →